Literature DB >> 19577606

Minimum tolerable exposure period and maximum threshold dietary intake of ochratoxin A for causing renal cancer in male Dark Agouti rats.

Peter G Mantle1.   

Abstract

In rats fed dietary ochratoxin A (5 ppm for 3, 6 or 9 months) no renal tumours occurred throughout natural life of the group treated for 3 months, during which the ochratoxin dose was 3 times that in the high dose group of the NTP study. Bilateral renal carcinoma occurred in one rat in the 6 month group. Four rats treated for 9 months developed unilateral renal carcinoma. Overall latency between ceasing toxin exposure and discovering tumours was 35-97 weeks. Experimental verification of a 'no observable effect level' was made for feed containing 400 ppb, equivalent to approximately 7 microg ochratoxin A/day for Dark Agouti rats for up to 2 years, during which mean daily dose commenced at approximately 50 microg/kg, but later for adults was in the range 30-20 microg/kg. This data doubles the daily in vivo threshold dose from the NTP study ( approximately 15 microg/kg), and could influence human risk assessment. An at least 3 month threshold period for exposure to exceptionally high daily OTA intake (90 microg; 640-450 microg/kg) raises doubts over interpretation of experimental molecular data for OTA exposure at lower dose for up to 3 months in studies aimed at understanding carcinogenic mechanism.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19577606     DOI: 10.1016/j.fct.2009.05.043

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  11 in total

1.  Evidence for a role of oxidative stress in the carcinogenicity of ochratoxin a.

Authors:  M Marin-Kuan; V Ehrlich; T Delatour; C Cavin; B Schilter
Journal:  J Toxicol       Date:  2011-06-22

2.  Oncological outcomes in rats given nephrocarcinogenic exposure to dietary ochratoxin a, followed by the tumour promoter sodium barbital for life: a pilot study.

Authors:  Peter G Mantle; Miloslav Dobrota; Cheryl E Gillett; Edward W Odell; Sarah E Pinder
Journal:  Toxins (Basel)       Date:  2010-03-31       Impact factor: 4.546

3.  Pathological outcomes in kidney and brain in male Fischer rats given dietary ochratoxin A, commencing at one year of age.

Authors:  Peter G Mantle; Christopher C Nolan
Journal:  Toxins (Basel)       Date:  2010-05-13       Impact factor: 4.546

4.  H NMR spectroscopy-based metabolomic assessment of uremic toxicity, with toxicological outcomes, in male rats following an acute, mid-life insult from ochratoxin a.

Authors:  Peter G Mantle; Andrew W Nicholls; John P Shockcor
Journal:  Toxins (Basel)       Date:  2011-05-26       Impact factor: 4.546

Review 5.  A reassessment of risk associated with dietary intake of ochratoxin A based on a lifetime exposure model.

Authors:  Lois A Haighton; Barry S Lynch; Bernadene A Magnuson; Earle R Nestmann
Journal:  Crit Rev Toxicol       Date:  2012-02       Impact factor: 5.635

6.  Contribution of organ vasculature in rat renal analysis for ochratoxin a: relevance to toxicology of nephrotoxins.

Authors:  Peter Mantle; Mehmet A Kilic; Firdevs Mor; Ozlem Ozmen
Journal:  Toxins (Basel)       Date:  2015-03-24       Impact factor: 4.546

7.  Rat Kidney Cancers Determined by Dietary Ochratoxin A in the First Year of Life.

Authors:  Peter Mantle
Journal:  J Kidney Cancer VHL       Date:  2016-09-26

Review 8.  Immunohistochemical Review of Leydig Cell Lesions in Ochratoxin A-Treated Fischer Rats and Controls.

Authors:  Diana Herman; Peter Mantle
Journal:  Toxins (Basel)       Date:  2019-08-20       Impact factor: 4.546

9.  Auditory brainstem responses in aging dark agouti rats.

Authors:  Angela K Beltrame; Nancy M Dahms; Christina L Runge
Journal:  Biosci Rep       Date:  2021-02-26       Impact factor: 3.840

10.  Comparative immunohistochemical analysis of ochratoxin A tumourigenesis in rats and urinary tract carcinoma in humans; mechanistic significance of p-S6 ribosomal protein expression.

Authors:  Patrycja Gazinska; Diana Herman; Cheryl Gillett; Sarah Pinder; Peter Mantle
Journal:  Toxins (Basel)       Date:  2012-09-11       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.